How to explain the 'watch-and-wait' period to a CLL patient?
The question of drug combinations for consolidation and maintenance for multiple myeloma
Allogeneic transplant for older AML patients - who, when and how
Multiple myeloma highlights from ASCO 2016: monoclonal antibodies and oral proteasome inhibitors
Lymphoma: chemotherapy vs. bendamustine
Mathias J Rummel